Inventor · disambiguated record
Gerard Drewes
Also filed as: DREWES GERARD
6 granted patents·17 pending applications·62 citations·filing 1992–2011
81Inventor score
Top patents by PatentIndex Score
23 records- 0182US7408027B1Tools for the diagnosis and treatment of Alzheimer's diseaseMAX PLANCK GESELLSCHAFT·Filed 2000·Granted Aug 5, 2008·15 cites·4 claims
- 0273US7176290B2Tools for the diagnosis and treatment of Alzheimer's diseaseMAX PLANCK GESELLSCHAFT·Filed 2002·Granted Feb 13, 2007·5 cites·5 claims
- 0373US6200768B1Method of screening for compounds that dissolve paired helical filamentsMAX PLANCK GESELLSCHAFT·Filed 1992·Granted Mar 13, 2001·37 cites·1 claims
- 0465US7485712B2Protein kinase (NPK-110)MAX PLANCK GESELLSCHAFT·Filed 2003·Granted Feb 3, 2009·3 cites·3 claims
- 0550US2009162336A1Novel Tools for the Diagnosis and Treatment of Alzheimer's DiseaseMAX PLANCK GES ZUR FORDERUNGDE·Filed 2008·Application pending·0 cites
- 0648US2011028405A1Sulfamides as zap-70 inhibitorsHARRISON RICHARD JOHN·Filed 2008·Application pending·0 cites
- 0748US2011098288A1Sulfonamides as zap-70 inhibitorsMAJOR JEREMY·Filed 2009·Application pending·0 cites
- 0844US2012178180A1Methods for the identification of zap-70 interacting molecules and for the purification of zap-70KRUSE ULRICH·Filed 2007·Application pending·0 cites
- 0944US2009098105A1Treatment of neurodegenerative diseases by the use of scd4 inhibitorsHOPF CARSTEN·Filed 2004·Application pending·0 cites
- 1044US2011070595A1Methods for the identification of parp interacting molecules and for purification of parp proteinsCELLZOME AG·Filed 2009·Application pending·0 cites
- 1144US2007298029A1Treatment of Neurodegenerative Diseases by the Use of Degs InhibitorsHOPF CARSTEN·Filed 2004·Application pending·0 cites
- 1243US2007161554A1Treatment of neurodegenerative diseases by the use of laptm4bCELLZOME AG·Filed 2004·Application pending·0 cites
- 1342US2006264610A1Protein complexes of the tip60 transcriptional activator proteinCELLZOME AG·Filed 2003·Application pending·0 cites
- 1442US2013210664A1Methods for the Identification of Methyltransferase Interacting Molecules and for the Purification of Methyltransferase ProteinsHARRISON JOHN·Filed 2011·Application pending·0 cites
- 1538US2008025969A1Treatment of Neurodegenerative Diseases by the Use of Gpr49CELL ZOME AG·Filed 2004·Application pending·0 cites
- 1638US2007280927A1Treatment Of Neurodegenerative Diseases By The Use Of Atp7aCELLZOME AG·Filed 2004·Application pending·0 cites
- 1736US2009238808A1Process for the identification of novel enzyme interacting compoundsDREWES GERARD·Filed 2007·Application pending·0 cites
- 1835US6579691B1Protein kinase NPK-110MAX PLANCK GESELLSCHAFT·Filed 1995·Granted Jun 17, 2003·2 cites·5 claims
- 1935US2008213250A1Use of Eph Receptor Inhibitors for the Treatment of Neurodegenerative DiseasesHOPF CARSTEN·Filed 2005·Application pending·0 cites
- 2034US8163511B2Methods for the identification of LRRK2 interacting moleculesDREWES GERARD·Filed 2007·Granted Apr 24, 2012·0 cites·26 claims
- 2134US2008038249A1Treatment Of Neurodegenerative Diseases By The Use Of Laptm4aCELLZOME AG·Filed 2005·Application pending·0 cites
- 2228US2013071854A1Methods for the identification and characterization of hdac interacting compoundsDREWES GERARD·Filed 2010·Application pending·0 cites
- 2327US2013210030A1In vivo method for the evaluation of a compound-target interactionDREWES GERARD·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →